tiprankstipranks
Trending News
More News >
Sleep Number (SNBR)
NASDAQ:SNBR

Sleep Number (SNBR) AI Stock Analysis

Compare
445 Followers

Top Page

SNBR

Sleep Number

(NASDAQ:SNBR)

Select Model
Select Model
Select Model
Neutral 48 (OpenAI - 5.2)
Rating:48Neutral
Price Target:
$10.00
▼(-15.33% Downside)
The score is held down primarily by weak financial performance—declining sales, negative margins, negative equity, and stressed cash flows. Offsetting this, technicals have improved with the stock trading above key moving averages and positive MACD, while the earnings call and recent initiatives (cost-out, credit agreement extension, marketing changes) add some support but still come with near-term cash burn and sales pressure.
Positive Factors
Cost Reduction Execution
Sizable, executed opex reductions are a durable lever to restore operating profitability and extend runway. Sustained lower fixed costs improve operating leverage versus volume, increasing the chance of positive adjusted EBITDA and cash flow as revenue stabilizes, aiding turnaround execution.
Credit Agreement Extension
Extending the credit facility materially reduces near-term refinancing risk and provides covenant flexibility to execute restructuring and growth investments. Lender support buys time to implement structural changes, improving odds of achieving sustainable cash generation before maturities pressure the balance sheet.
Marketing Efficiency Gains
Improved customer acquisition efficiency is a durable driver of unit economics: lower CAC raises ROI on marketing spend, enabling more productive growth investments when marketing is scaled. Persistent CAC improvements support margin recovery and better lifetime value economics over time.
Negative Factors
Revenue Decline & Negative Margins
Ongoing top-line contraction combined with negative operating and net margins signals structural demand or competitive positioning issues. Without a durable reversal in revenue trends, fixed-cost absorption and margin recovery will remain constrained, limiting sustainable profitability improvement.
Negative Equity & High Leverage
Negative equity and elevated leverage materially weaken financial resilience and strategic optionality. This capital structure raises refinancing and covenant risk, increases cost of capital, and likely necessitates recapitalization or sustained cash generation to restore solvency and support long-term investments.
Negative Operating and Free Cash Flow
Persistent negative OCF and FCF undermine the company's ability to fund capex, store consolidation, and product investments internally. Reliance on external financing or covenant amendments increases execution risk and can limit strategic flexibility until consistent positive cash generation is restored.

Sleep Number (SNBR) vs. SPDR S&P 500 ETF (SPY)

Sleep Number Business Overview & Revenue Model

Company DescriptionSleep Number Corporation, together with its subsidiaries, offers sleep solutions and services in the United States. The company designs, manufactures, markets, retails, and services beds, pillows, sheets, and other bedding products under the Sleep Number name. It also provides adjustable bases under the FlextFit, and smart beds under the Sleep Number 360 brands. The company sells its products directly to consumers through retail, online, phone, and chat as well as through its e-commerce activities. As of January 2, 2022, it operated approximately 648 retail stores in 50 states. The company was formerly known as Select Comfort Corporation and changed its name to Sleep Number Corporation in November 2017. Sleep Number Corporation was founded in 1987 and is headquartered in Minneapolis, Minnesota.
How the Company Makes MoneySleep Number generates revenue primarily through the sale of its customizable mattresses and related sleep products. The company's revenue model is centered around direct-to-consumer sales through its extensive network of retail stores and its e-commerce platform. Key revenue streams include the sale of mattresses, adjustable bases, bedding accessories, and smart sleep technology systems. Additionally, Sleep Number benefits from recurring revenue through the sale of replacement parts and accessories for their products. The company has also established partnerships with various health and wellness organizations to promote the importance of sleep health, which can drive brand awareness and customer loyalty, further contributing to its earnings.

Sleep Number Earnings Call Summary

Earnings Call Date:Sep 27, 2025
(Q3-2025)
|
Next Earnings Date:Feb 25, 2026
Earnings Call Sentiment Neutral
The earnings call highlighted significant financial restructuring and cost reduction efforts, which are expected to support future growth. However, the company's current financial performance, including a notable decline in sales and profits, reflects ongoing challenges in the competitive landscape.
Q3-2025 Updates
Positive Updates
Bank Agreement Extension
Secured an amendment and extension of the bank agreement through 2027, providing financial flexibility to focus on sales-driving initiatives and execute the turnaround strategy.
Cost Reduction Achievements
Reduced operating expenses, excluding restructuring and nonrecurring costs, by $115 million with an expectation to exceed the $130 million cost-out target for 2025.
Marketing Efficiency Improvements
Achieved a 6% decline in cost per acquisition versus the prior year, with improvements in marketing efficiency expected to drive increased traffic in the future.
Negative Updates
Q3 Revenue Decline
Net sales of $343 million were down 19.6% year-over-year, driven by reduced marketing and media investments and increased competition.
Profit and Cash Flow Below Expectations
Profits and cash flow were well below expectations, resulting in a reduction of full year net sales, adjusted EBITDA, and free cash flow expectations.
Gross Profit Margin Decline
Gross profit margin was 59.9%, down 93 basis points versus last year, mainly due to unit volume deleverage.
Restructuring and Nonrecurring Costs
Recorded $41 million in restructuring and other nonrecurring costs in Q3, with significant noncash charges related to asset impairments.
Company Guidance
During the Q3 2025 earnings call, Sleep Number provided guidance that emphasized a strategic turnaround aimed at stabilizing and growing sales in 2026. The company reported a 19.6% decline in Q3 net sales to $343 million, with a gross profit margin of 59.9%. Operating expenses, excluding restructuring costs, fell by 18% year-over-year to $204 million. Despite a challenging competitive environment and media spend reductions of 32% in Q2 and Q3, Sleep Number is optimistic about future prospects. They secured an amendment to their bank agreement through 2027, allowing for increased financial flexibility to invest in growth initiatives. The company expects full-year 2025 net sales of approximately $1.4 billion, with adjusted EBITDA of around $70 million and a negative free cash flow of approximately $50 million. Looking ahead, Sleep Number plans to simplify its product offerings, enhance marketing strategies, optimize its distribution model, and continue cost reduction efforts, including a focus on real estate consolidation, to drive improved financial performance in 2026.

Sleep Number Financial Statement Overview

Summary
Overall financials are weak: revenue is declining (TTM down 5.49%) and profitability is pressured with negative net/EBIT/EBITDA margins. The balance sheet is a major risk due to negative stockholders’ equity and high leverage, while cash flow remains challenged with negative operating and free cash flow in the TTM period.
Income Statement
45
Neutral
Sleep Number's income statement reveals a challenging period with declining revenue and profitability. The TTM data shows a negative net profit margin of -2.66% and a gross profit margin of 60.05%, indicating pressure on profitability. Revenue has decreased by 5.49% compared to the previous period, reflecting a downward trend. The EBIT and EBITDA margins are also negative, highlighting operational challenges. Overall, the income statement reflects a need for strategic improvements to reverse the declining trend.
Balance Sheet
30
Negative
The balance sheet shows significant financial leverage with a negative stockholders' equity, resulting in a concerning debt-to-equity ratio. The TTM data indicates a debt-to-equity ratio of -0.69, suggesting high financial risk. Return on equity is positive at 8.03%, but the negative equity position poses a risk to financial stability. The equity ratio is not calculable due to negative equity, underscoring the need for capital restructuring.
Cash Flow
40
Negative
Cash flow analysis reveals substantial challenges with negative operating and free cash flows in the TTM period. The free cash flow growth rate is positive at 268.83%, but this is from a negative base, indicating volatility. The operating cash flow to net income ratio is negative, reflecting cash flow difficulties. The free cash flow to net income ratio is 1.63, suggesting some ability to cover net losses with free cash flow, but overall cash flow stability is a concern.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue1.44B1.68B1.89B2.11B2.18B1.86B
Gross Profit865.25M1.00B1.09B1.20B1.32B1.16B
EBITDA22.84M89.22M95.34M135.28M253.93M246.46M
Net Income-78.11M-20.33M-15.29M36.61M153.75M139.19M
Balance Sheet
Total Assets749.39M860.81M950.88M953.94M919.54M800.14M
Cash, Cash Equivalents and Short-Term Investments1.26M1.95M2.54M1.79M2.39M4.24M
Total Debt940.71M936.11M972.65M896.01M791.05M589.36M
Total Liabilities1.27B1.31B1.39B1.39B1.34B1.02B
Stockholders Equity-521.34M-451.59M-441.93M-438.18M-424.95M-223.98M
Cash Flow
Free Cash Flow-49.98M3.64M-66.08M-33.32M233.11M240.59M
Operating Cash Flow-28.52M27.14M-9.03M36.14M300.01M279.66M
Investing Cash Flow-21.45M-26.29M-58.35M-70.61M-66.64M-39.02M
Financing Cash Flow49.65M-1.44M68.13M33.87M-235.22M-237.99M

Sleep Number Technical Analysis

Technical Analysis Sentiment
Positive
Last Price11.81
Price Trends
50DMA
8.37
Positive
100DMA
7.38
Positive
200DMA
7.95
Positive
Market Momentum
MACD
0.91
Negative
RSI
66.51
Neutral
STOCH
72.71
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SNBR, the sentiment is Positive. The current price of 11.81 is above the 20-day moving average (MA) of 10.08, above the 50-day MA of 8.37, and above the 200-day MA of 7.95, indicating a bullish trend. The MACD of 0.91 indicates Negative momentum. The RSI at 66.51 is Neutral, neither overbought nor oversold. The STOCH value of 72.71 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SNBR.

Sleep Number Risk Analysis

Sleep Number disclosed 2 risk factors in its most recent earnings report. Sleep Number reported the most risks in the "Legal & Regulatory" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Sleep Number Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
77
Outperform
$1.54B17.188.82%2.39%1.78%-25.36%
70
Outperform
$588.06M13.449.21%7.86%-4.26%
63
Neutral
$1.65B7.5926.20%1.84%-6.03%
61
Neutral
$18.38B12.79-2.54%3.03%1.52%-15.83%
61
Neutral
$1.40B-54.03-1.95%4.16%4.34%-141.36%
48
Neutral
$253.88M-3.46-16.95%-88.00%
48
Neutral
$72.85M-1.26-9999.00%-9.47%48.11%
* Consumer Cyclical Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SNBR
Sleep Number
11.81
-6.19
-34.39%
ETD
Ethan Allen
23.33
-5.34
-18.63%
MLKN
MillerKnoll
20.79
-0.06
-0.28%
LZB
La-Z-Boy Incorporated
37.24
-8.89
-19.27%
LEG
Leggett & Platt
12.36
2.14
20.92%
PRPL
Purple Innovation
0.66
-0.43
-39.17%

Sleep Number Corporate Events

Business Operations and StrategyPrivate Placements and Financing
Sleep Number launches strategic partnership with Travis Kelce
Positive
Jan 28, 2026

On January 28, 2026, Sleep Number announced a three-year strategic partnership and investment deal with three-time Super Bowl champion Travis Kelce, who has used the company’s products since 2019. Under the agreement, Kelce and his company TMK Enterprises LLC will collaborate on national advertising and digital content to promote the performance and wellness benefits of Sleep Number beds, while Kelce receives cash and restricted stock units that vest over three years and commits to buying additional shares on the open market, making him one of the company’s largest shareholders with under 5% ownership. The deal deepens Sleep Number’s long-standing relationship with the NFL—where 83% of players have Sleep Number beds—and is a key element of the company’s broader effort to overhaul its marketing strategy, sharpen brand visibility and attract younger consumers by leveraging Kelce’s high profile and alignment with sleep-focused performance.

The most recent analyst rating on (SNBR) stock is a Hold with a $10.50 price target. To see the full list of analyst forecasts on Sleep Number stock, see the SNBR Stock Forecast page.

Business Operations and StrategyExecutive/Board Changes
Sleep Number Appoints New CFO Amid Strategic Shift
Positive
Dec 2, 2025

On December 2, 2025, Sleep Number Corporation announced the appointment of Amy K. O’Keefe as the new Chief Financial Officer, effective December 8, 2025, succeeding interim CFO Robert P. Ryder. O’Keefe brings over 30 years of experience in financial transformations across various sectors, and her appointment is part of Sleep Number’s strategy to stabilize and grow the business. The company also reaffirmed its full-year 2025 financial guidance and outlined a focused turnaround strategy in an updated investor presentation, emphasizing cost reductions, operational improvements, and financial flexibility.

The most recent analyst rating on (SNBR) stock is a Sell with a $4.00 price target. To see the full list of analyst forecasts on Sleep Number stock, see the SNBR Stock Forecast page.

Business Operations and StrategyPrivate Placements and Financing
Sleep Number Secures Credit Agreement Extension
Positive
Nov 10, 2025

Sleep Number Corporation announced on November 5, 2025, that it has secured an amendment and extension of its credit agreement through 2027, which aligns with its planned turnaround strategy. This updated agreement, reflecting increased covenant levels and expanded addbacks, demonstrates lender confidence and provides financial flexibility, supporting the company’s expectation to comply with new covenants and generate meaningful free cash flow in 2026.

The most recent analyst rating on (SNBR) stock is a Sell with a $5.00 price target. To see the full list of analyst forecasts on Sleep Number stock, see the SNBR Stock Forecast page.

Executive/Board ChangesPrivate Placements and Financing
Sleep Number Amends Credit Agreement, Extends Maturity Date
Neutral
Nov 5, 2025

On November 4, 2025, Sleep Number Corporation executed a Twelfth Amendment to its Credit and Security Agreement, extending the maturity date to December 3, 2027, and adjusting various financial covenants and credit facilities. This amendment signifies a strategic financial restructuring for the company, ensuring compliance with all covenants and facilitating the retirement of Board member Stephen L. Gulis, Jr., who stepped down following the amendment’s qualification as a debt refinancing.

The most recent analyst rating on (SNBR) stock is a Sell with a $5.00 price target. To see the full list of analyst forecasts on Sleep Number stock, see the SNBR Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jan 29, 2026